Cost‐effectiveness of dapagliflozin as an adjunct to insulin for the treatment of type 1 diabetes mellitus in the United Kingdom

Hayley Bennett; Amarjeet Tank; Marc Evans; Klas Bergenheim; Phil McEwan

doi:10.1111/dom.13992

Cost‐effectiveness of dapagliflozin as an adjunct to insulin for the treatment of type 1 diabetes mellitus in the United Kingdom

Diabetes Obesity and Metabolism ◽

10.1111/dom.13992 ◽

2020 ◽

Vol 22 (7) ◽

pp. 1047-1055 ◽

Cited By ~ 1

Author(s):

Hayley Bennett ◽

Amarjeet Tank ◽

Marc Evans ◽

Klas Bergenheim ◽

Phil McEwan

Keyword(s):

Diabetes Mellitus ◽

Type 1 Diabetes ◽

United Kingdom ◽

Cost Effectiveness ◽

Type 1 Diabetes Mellitus ◽

The United Kingdom

Download Full-text

Cost-Effectiveness of Insulin Degludec Compared with Insulin Glargine in a Basal-Bolus Regimen in Patients with Type 1 Diabetes Mellitus in the United Kingdom

Value in Health ◽

10.1016/j.jval.2013.08.685 ◽

2013 ◽

Vol 16 (7) ◽

pp. A442

Author(s):

B. Chubb ◽

M. Evans ◽

M. Wolden ◽

T. Christensen ◽

J. Gundgaard

Keyword(s):

Diabetes Mellitus ◽

Type 1 Diabetes ◽

United Kingdom ◽

Cost Effectiveness ◽

Insulin Glargine ◽

Type 1 Diabetes Mellitus ◽

Insulin Degludec ◽

The United Kingdom ◽

Basal Bolus

Download Full-text

The cost of Type 1 diabetes mellitus in the United Kingdom: a review of cost-of-illness studies

The European Journal of Health Economics ◽

10.1007/s10198-012-0433-4 ◽

2012 ◽

Vol 14 (6) ◽

pp. 887-899 ◽

Cited By ~ 4

Author(s):

Jen Kruger ◽

Alan Brennan

Keyword(s):

Diabetes Mellitus ◽

Type 1 Diabetes ◽

United Kingdom ◽

Type 1 Diabetes Mellitus ◽

Cost Of Illness ◽

The United Kingdom ◽

The Cost ◽

Cost Of Illness Studies

Download Full-text

936-P: Annual Cost to Achieve Cost Effectiveness of Continuous Glucose Monitoring in Hypoglycemia-Unaware Type 1 Diabetes Patients Using Intensive Insulin in the United Kingdom

Diabetes ◽

10.2337/db19-936-p ◽

2019 ◽

Vol 68 (Supplement 1) ◽

pp. 936-P

Author(s):

S. PINAR BILIR ◽

CARESSE CAMPBELL ◽

RICHARD HELLMUND ◽

JULIE MUNAKATA

Keyword(s):

Type 1 Diabetes ◽

United Kingdom ◽

Cost Effectiveness ◽

Continuous Glucose Monitoring ◽

Annual Cost ◽

Glucose Monitoring ◽

The United Kingdom ◽

Diabetes Patients

Download Full-text

Treating Type 1 Diabetes Mellitus with a Rapid-Acting Analog Insulin Regimen vs. Regular Human Insulin in Germany: A Long-Term Cost-Effectiveness Evaluation

Applied Health Economics and Health Policy ◽

10.1007/s40258-018-0379-5 ◽

2018 ◽

Vol 16 (3) ◽

pp. 357-366 ◽

Cited By ~ 2

Author(s):

William J. Valentine ◽

Kate Van Brunt ◽

Kristina S. Boye ◽

Richard F. Pollock

Keyword(s):

Diabetes Mellitus ◽

Type 1 Diabetes ◽

Cost Effectiveness ◽

Type 1 Diabetes Mellitus ◽

Effectiveness Evaluation ◽

Insulin Regimen ◽

Regular Human Insulin ◽

Analog Insulin

Download Full-text

Cost-effectiveness of insulin degludec compared with insulin glargine in a basal-bolus regimen in patients with type 1 diabetes mellitus in the UK

Journal of Medical Economics ◽

10.3111/13696998.2014.971160 ◽

2014 ◽

Vol 18 (1) ◽

pp. 56-68 ◽

Cited By ~ 26

Author(s):

M. Evans ◽

M. Wolden ◽

J. Gundgaard ◽

B. Chubb ◽

T. Christensen

Keyword(s):

Diabetes Mellitus ◽

Type 1 Diabetes ◽

Cost Effectiveness ◽

Insulin Glargine ◽

Type 1 Diabetes Mellitus ◽

Insulin Degludec ◽

The Uk ◽

Basal Bolus

Download Full-text

PDB22 LONG-TERM COST-EFFECTIVENESS OF INSULIN ASPART VERSUS SOLUBLE HUMAN INSULIN IN PATIENTS WITH TYPE 1 DIABETES IN THE UNITED KINGDOM

Value in Health ◽

10.1016/s1098-3015(10)62955-5 ◽

2005 ◽

Vol 8 (3) ◽

pp. 358-359 ◽

Cited By ~ 4

Author(s):

ME Minshall ◽

NS Twena ◽

L Nicklasson ◽

S Roze

Keyword(s):

Type 1 Diabetes ◽

United Kingdom ◽

Cost Effectiveness ◽

Human Insulin ◽

Insulin Aspart ◽

The United Kingdom

Download Full-text

Clinical relevance and cost-effectiveness of HLA genotyping in children with Type 1 diabetes mellitus in screening for coeliac disease in the Netherlands

Diabetic Medicine ◽

10.1111/dme.12658 ◽

2014 ◽

Vol 32 (6) ◽

pp. 834-838 ◽

Cited By ~ 17

Author(s):

J. Elias ◽

J. J. G. Hoorweg-Nijman ◽

W. A. Balemans

Keyword(s):

Diabetes Mellitus ◽

Type 1 Diabetes ◽

Cost Effectiveness ◽

The Netherlands ◽

Coeliac Disease ◽

Type 1 Diabetes Mellitus ◽

Clinical Relevance ◽

Hla Genotyping

Download Full-text

PMD82 - COST-EFFECTIVENESS OF INSULIN PUMP THERAPY IN ADULTS WITH TYPE 1 DIABETES MELLITUS (T1DM)- THE EMIPE STUDY : A REAL-LIFE EVIDENCE STUDY IN FRANCE

Value in Health ◽

10.1016/j.jval.2018.09.1531 ◽

2018 ◽

Vol 21 ◽

pp. S257

Author(s):

J. Dinet ◽

V. Georgescu ◽

G. Bourel ◽

E. Renard

Keyword(s):

Diabetes Mellitus ◽

Type 1 Diabetes ◽

Cost Effectiveness ◽

Type 1 Diabetes Mellitus ◽

Insulin Pump ◽

Real Life ◽

Insulin Pump Therapy ◽

Pump Therapy

Download Full-text

Cost Effectiveness of ACE Inhibitor Treatment for Patients with Type 1 Diabetes Mellitus

PharmacoEconomics ◽

10.2165/00019053-200422150-00005 ◽

2004 ◽

Vol 22 (15) ◽

pp. 1015-1027 ◽

Cited By ~ 12

Author(s):

Frederick B Dong ◽

Stephen W Sorensen ◽

Diane L Manninen ◽

Theodore J Thompson ◽

Venkat Narayan ◽

...

Keyword(s):

Diabetes Mellitus ◽

Type 1 Diabetes ◽

Cost Effectiveness ◽

Type 1 Diabetes Mellitus ◽

Ace Inhibitor ◽

Inhibitor Treatment

Download Full-text

PDB52 Cost-Effectiveness of Renal Screening Strategies and Treatment Options for Patients With Type 1 Diabetes in the United Kingdom

Value in Health ◽

10.1016/j.jval.2012.03.973 ◽

2012 ◽

Vol 15 (4) ◽

pp. A180

Author(s):

T.W. Lung ◽

A.J. Hayes ◽

P.M. Clarke ◽

R.J. Stevens ◽

A. Farmer

Keyword(s):

Type 1 Diabetes ◽

United Kingdom ◽

Cost Effectiveness ◽

Treatment Options ◽

The United Kingdom ◽

Screening Strategies ◽

Renal Screening

Download Full-text